Current Liabilities
Compensation and benefits
Neurocrine Biosciences Compensation and benefits decreased by 36.6% to $81.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.1%, from $57.50M to $81.70M. Over 3 years (FY 2022 to FY 2025), Compensation and benefits shows an upward trend with a 20.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2022
Last reportedQ1 2026May 5, 2026
How to read this metric
An increase often correlates with seasonal bonus cycles or headcount growth, while a decrease may signal payout timing changes.
Detailed definition
This represents short-term obligations to employees, including unpaid wages, bonuses, commissions, and vacation pay. It...
Peer comparison
Service-based companies typically carry higher employee-related liabilities than capital-intensive firms.
Metric ID:
current_liabilities_employee_related_liabilities_currentHistorical Data
12 periods
| Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $72.80M | $68.60M | $86.20M | $42.60M | $59.80M | $77.10M | $107.50M | $57.50M | $84.60M | $105.10M | $128.80M | $81.70M |
| QoQ Change | — | -5.8% | +25.7% | -50.6% | +40.4% | +28.9% | +39.4% | -46.5% | +47.1% | +24.2% | +22.5% | -36.6% |
| YoY Change | — | — | +18.4% | — | — | +12.4% | +24.7% | +35.0% | +41.5% | +36.3% | +19.8% | +42.1% |
Range$42.60M – $128.80M
CAGR+4.3%
Avg YoY Growth+28.8%
Median YoY Growth+29.8%
Compensation and benefits at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's compensation and benefits?
- Neurocrine Biosciences (NBIX) reported compensation and benefits of $81.70M in Q1 2026.
- How has Neurocrine Biosciences's compensation and benefits changed year-over-year?
- Neurocrine Biosciences's compensation and benefits increased by 42.1% year-over-year, from $57.50M to $81.70M.
- What is the long-term trend for Neurocrine Biosciences's compensation and benefits?
- Over 3 years (2022 to 2025), Neurocrine Biosciences's compensation and benefits has grown at a 20.9% compound annual growth rate (CAGR), from $72.80M to $128.80M.
- What does compensation and benefits mean?
- Short-term debts owed to employees for earned wages, bonuses, and benefits.